Just one week after clearance, our first four commercial Hēlo® cases are complete.
Over the past four days, Dr. George So and the team at @TMHealthSystem completed the first four commercial procedures with the Hēlo® Thrombectomy System.
We're grateful for the care they provide for their patients, and proud that Hēlo® is helping patients in need.
Four patients treated, and many more to come.
Rx Only. Clinical outcomes may vary. Learn more: bit.ly/4BjLN6Q
Cleared.
The Hēlo® Thrombectomy System and Blood Return System are now FDA 510(k) cleared.
Designed for PE and venous clot removal, with a focus on single-pass performance and high-quality blood return.
This is just the beginning — next chapter starts now.
Read the full announcement → prnewswire.com/news-releases…
#PulmonaryEmbolism #VTE #Thrombectomy #510k #E2Helo #ClearedForTakeOff
Thanks to Steve Maxson for having our CEO, Dan Rose, on MedTech Unboxed to discuss the evolving landscape of pulmonary embolism treatment, the innovation behind the Hēlo® Thrombectomy System, and E2's vision for advancing PE care.
#PulmonaryEmbolism #Thrombectomy #MedTech #E2Helo
Episode 4: Bench to Table
From the first prototype to the people, systems & purpose behind it all — the final episode of our Bench to Table series explores how innovation becomes impact for PE patients.
The Hēlo® Blood Return System is pending 510(k) clearance.
#MedTech #E2Hēlo #PulmonaryEmbolism #MechanicalThrombectomy
youtu.be/WbMgSPpS8ew?si=
Episode 3: Bench to Manufacturing
How do you scale from hand-built prototypes to manufacturing hundreds to thousands of devices?
Episode 3 of our Bench to Table series covers how we scaled manufacturing without compromising quality.
#MedTech #E2Hēlo #MechanicalThrombectomy #PulmonaryEmbolism
youtu.be/gP4LsGZzTuk?si=
Episode 2: Bench to Study
Clinical studies aren't just about reaching the next milestone — they're an opportunity to learn, iterate, and improve.
Episode 2 of our Bench to Table series follows the Hēlo® platform from feasibility through the ENGULF IDE Study, highlighting how clinical insights along the way helped refine its design. 🎬
#MedTech #PulmonaryEmbolism #E2Hēlo #MechanicalThrombectomy
youtu.be/dTkeKYfdmNY?si=
Episode 1: Idea to Bench
From a lab at U of Michigan to a bold pivot targeting Pulmonary Embolism — this is how the Hēlo® Thrombectomy System was born.
🎬Watch our Bench to Table series.
#MedTech #PulmonaryEmbolism #E2Hēlo #MechanicalThrombectomy
youtu.be/C3iatLv66_Y?si=
Introducing the Hēlo® Thrombectomy System.
A purpose-built mechanical thrombectomy system designed specifically for pulmonary embolism (PE) intervention, Hēlo® represents Endovascular Engineering's (E2) commitment to advancing PE treatment through thoughtful, innovative engineering.
Follow us for company milestones, clinical updates, case highlights, educational content, and the latest developments in PE intervention.
#MedTech #PulmonaryEmbolism #E2Hēlo #MechanicalThrombectomy



